Physician

Christopher Ugochukwu Ugorji Rex, M.D.

According to 2025 Medicare claims, Christopher Rex, M.D. (NPI: 1083054571) practices dermatology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is INNOVATIVE DERMATOLOGY ALLIANCE CA (NPI: 1083188221; TIN: 832198681) and primary practice location at 93291-5174. Rex is affiliated with the Banner Health Network (ACO ID: A3229), Adventist Health Accountable Care, LLC (ACO ID: A3873), and Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Rex's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,560 traditional Medicare patients, billed 215,759 HCPCS/CPT codes, and received $5,173,823 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,255 prescription claims across 564 beneficiaries totaling $183,575 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 59 records totaling $1,285. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,576 to $5,173,823. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,922 to $183,575. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	74	365	$20,576
2018	594	8,617	$170,686
2019	946	32,833	$384,973
2020	1,048	28,552	$486,351
2021	1,228	41,947	$634,195
2022	1,166	36,139	$769,739
2023	1,605	55,115	$1,036,055
2024	2,560	215,759	$5,173,823

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	23	$2,922
2016	N/R	19	$1,257
2017	52	91	$5,479
2018	253	458	$15,245
2019	448	847	$53,159
2020	571	1,208	$228,594
2021	601	1,289	$139,998
2022	566	1,267	$358,925
2023	538	1,131	$299,133
2024	564	1,255	$183,575

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	885	1,166	$86
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	1,025	1,025	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,618	3,132	$69
17000	Destruction of precancer skin growth, 1 growth	1,197	1,829	$39
17003	Destruction of precancer skin growth, 2-14 growths	937	6,234	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	140	3,840	$5,371
Ketoconazole	Ketoconazole	264	7,400	$4,107
Betamethasone Dipropionate	Betamethasone Dipropionate	22	603	$1,177
Fluconazole	Fluconazole	59	600	$1,143
Triamcinolone Acetonide	Triamcinolone Acetonide	125	3,379	$1,122

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$1,285	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Ugochukwu Ugorji Rex, M.D.?

Tedicare shows public-source Medicare data for Christopher Ugochukwu Ugorji Rex, M.D. (NPI 1083054571), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Ugochukwu Ugorji Rex, M.D. have ACO affiliation data?

Christopher Ugochukwu Ugorji Rex, M.D. is shown with ACO affiliation data for Banner Health Network (MSSP, ACO ID A3229), Adventist Health Accountable Care, LLC (MSSP, ACO ID A3873), and Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Christopher Ugochukwu Ugorji Rex, M.D.?

Christopher Ugochukwu Ugorji Rex, M.D. is linked to INNOVATIVE DERMATOLOGY ALLIANCE CA (billing NPI 1083188221) in the available physician profile data.

Does Christopher Ugochukwu Ugorji Rex, M.D. have Open Payments data?

Christopher Ugochukwu Ugorji Rex, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.